IIM
ALT icon

INTECH Investment Management’s Altimmune ALT Stock Holding History

INTECH Investment Management’s Portfolio ALT Stock Details ALT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$94.7K Sell
30,761
-21,796
-41% -$92.5K ﹤0.01% 1903
2025
Q4 		$190K Buy
52,557
+13,918
+36% +$60.7K ﹤0.01% 2007
2025
Q3 		$146K Sell
38,639
-106,251
-73% -$410K ﹤0.01% 2162
2025
Q2 		$561K Buy
144,890
+73,482
+103% +$398K 0.01% 1540
2025
Q1 		$357K Buy
71,408
+25,285
+55% +$160K ﹤0.01% 1794
2024
Q4 		$333K Buy
46,123
+12,385
+37% +$94.6K ﹤0.01% 1782
2024
Q3 		$207K Buy
+33,738
New +$229K ﹤0.01% 1700

Other funds holding ALT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

INTECH Investment Management's ALT Position: Q1 2026 in Review

INTECH Investment Management reduced its Altimmune (ALT) stake by 41% in Q1 2026, selling an estimated $92.5K and leaving 30,761 shares worth $94.7K. The position accounts for ﹤0.01% of the portfolio, ranked #1903.

INTECH Investment Management first reported a position in ALT in Q3 2024 and has held it in 7 quarters since. The position peaked at $561K in Q2 2025. 173 funds tracked by Wall St. Rank hold ALT as of Q1 2026.

  • INTECH Investment Management held 30,761 shares of Altimmune worth $94.7K as of Q1 2026.
  • INTECH Investment Management sold 21,796 Altimmune shares in Q1 2026, an estimated $92.5K.
  • Altimmune made up ﹤0.01% of INTECH Investment Management's portfolio in Q1 2026, its #1903 holding.
  • INTECH Investment Management first reported a position in Altimmune in Q3 2024 and has held it in 7 quarters since.
  • INTECH Investment Management's Altimmune position peaked at $561K in Q2 2025.
  • 173 funds tracked by Wall St. Rank held Altimmune as of Q1 2026.

Based on INTECH Investment Management's 13F filing for Q1 2026, filed 8 May 2026.